Skip to main content
. 2018 Jun 25;59(5):616–624. doi: 10.1093/jrr/rry047

Fig. 1.

Fig. 1.

Overall survival (OS) and relapse-free survival (RFS) for all patients. The 5-year OS and RFS rates were 57% (95% CI, 43–71%) and 55% (95% CI, 41–69%), respectively.